Mark Donahue

2.4k total citations
38 papers, 1.6k citations indexed

About

Mark Donahue is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Mark Donahue has authored 38 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 12 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Mark Donahue's work include Heart Failure Treatment and Management (12 papers), Cardiovascular Function and Risk Factors (5 papers) and Pharmacology and Obesity Treatment (3 papers). Mark Donahue is often cited by papers focused on Heart Failure Treatment and Management (12 papers), Cardiovascular Function and Risk Factors (5 papers) and Pharmacology and Obesity Treatment (3 papers). Mark Donahue collaborates with scholars based in United States, France and Belgium. Mark Donahue's co-authors include William E. Kraus, Christopher M. O’Connor, G. Michael Felker, Mona Fiuzat, Ileana L. Piña, David J. Whellan, Faı̈ez Zannad, Dalane W. Kitzman, Kirkwood F. Adams and Geoffrey S. Ginsburg and has published in prestigious journals such as Annals of Internal Medicine, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Mark Donahue

38 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Donahue United States 21 683 528 369 235 186 38 1.6k
Emmanuel Androulakis Greece 19 751 1.1× 379 0.7× 172 0.5× 242 1.0× 198 1.1× 106 1.7k
Fragiska Sigala Greece 27 555 0.8× 539 1.0× 188 0.5× 479 2.0× 180 1.0× 102 2.1k
Andrzej Surdacki Poland 21 930 1.4× 308 0.6× 177 0.5× 267 1.1× 572 3.1× 136 1.8k
Thimoteus Speer Germany 27 497 0.7× 640 1.2× 239 0.6× 534 2.3× 232 1.2× 80 2.5k
Nima Ghasemzadeh United States 23 862 1.3× 313 0.6× 128 0.3× 320 1.4× 97 0.5× 47 1.6k
Demetrios Vlahakos Greece 26 385 0.6× 392 0.7× 257 0.7× 155 0.7× 98 0.5× 71 1.8k
Marta Brambilla Italy 24 362 0.5× 424 0.8× 274 0.7× 222 0.9× 111 0.6× 78 1.8k
Mirjam Schuchardt Germany 24 492 0.7× 593 1.1× 153 0.4× 355 1.5× 240 1.3× 54 2.1k
Jürgen Meyer Germany 20 747 1.1× 578 1.1× 539 1.5× 697 3.0× 234 1.3× 32 2.6k
Danny J. Eapen United States 19 471 0.7× 202 0.4× 109 0.3× 208 0.9× 109 0.6× 45 1.1k

Countries citing papers authored by Mark Donahue

Since Specialization
Citations

This map shows the geographic impact of Mark Donahue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Donahue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Donahue more than expected).

Fields of papers citing papers by Mark Donahue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Donahue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Donahue. The network helps show where Mark Donahue may publish in the future.

Co-authorship network of co-authors of Mark Donahue

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Donahue. A scholar is included among the top collaborators of Mark Donahue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Donahue. Mark Donahue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sherwood, Andrew, James A. Blumenthal, Robert J. Mentz, et al.. (2024). Depressive Symptoms are Associated with Clinical Outcomes in Heart Failure with Reduced Ejection Fraction. ESC Heart Failure. 11(5). 2627–2636. 2 indexed citations
2.
Luzum, Jasmine A., Alessandra M. Campos‐Staffico, Jia Li, et al.. (2023). Genome-Wide Association Study of Beta-Blocker Survival Benefit in Black and White Patients with Heart Failure with Reduced Ejection Fraction. Genes. 14(11). 2019–2019. 1 indexed citations
3.
4.
O’Malley, Patrick G., Michael J Arnold, S. Natarajan, et al.. (2020). Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2020 Updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline. Annals of Internal Medicine. 173(10). 822–829. 46 indexed citations
5.
Rymer, Jennifer A., Colin O’Donnell, Mary E. Plomondon, et al.. (2019). Same-day discharge among patients undergoing elective PCI: Insights from the VA CART Program. American Heart Journal. 218. 75–83. 13 indexed citations
6.
Sharma, Abhinav, Susanna R. Stevens, Joseph Lucas, et al.. (2017). Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure. JACC Heart Failure. 5(10). 724–734. 79 indexed citations
7.
Ahmad, Tariq, Jacob P. Kelly, Robert W. McGarrah, et al.. (2016). Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support. Journal of the American College of Cardiology. 67(3). 291–299. 154 indexed citations
8.
Fiuzat, Mona, Phillip J. Schulte, G. Michael Felker, et al.. (2013). Relationship Between Galectin-3 Levels and Mineralocorticoid Receptor Antagonist Use in Heart Failure: Analysis From HF-ACTION. Journal of Cardiac Failure. 20(1). 38–44. 24 indexed citations
9.
Ahmad, Tariq, Mona Fiuzat, Daniel B. Mark, et al.. (2013). The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure. American Heart Journal. 167(2). 193–202.e1. 53 indexed citations
10.
Fiuzat, Mona, Megan L. Neely, Aijing Z. Starr, et al.. (2012). Association between Adrenergic Receptor Genotypes and Beta-Blocker Dose in Heart Failure Patients: Analysis from the HF-ACTION DNA Substudy. European Journal of Heart Failure. 15(3). 258–266. 33 indexed citations
11.
Felker, G. Michael, David J. Whellan, William E. Kraus, et al.. (2009). N-terminal pro–brain natriuretic peptide and exercise capacity in chronic heart failure: Data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study. American Heart Journal. 158(4). S37–S44. 26 indexed citations
12.
Sehnert, Amy J., Susan E. Daniels, Michael Elashoff, et al.. (2008). Lack of Association Between Adrenergic Receptor Genotypes and Survival in Heart Failure Patients Treated With Carvedilol or Metoprolol. Journal of the American College of Cardiology. 52(8). 644–651. 101 indexed citations
13.
Donahue, Mark, Douglas A. Marchuk, & Howard A. Rockman. (2006). Redefining Heart Failure. Journal of the American College of Cardiology. 48(7). 1289–1298. 42 indexed citations
14.
DeWald, Tracy A., Lalita Khaodhiar, Mark Donahue, & George L. Blackburn. (2006). Pharmacological and surgical treatments for obesity. American Heart Journal. 151(3). 604–624. 16 indexed citations
15.
Patel, Manesh R., Mark Donahue, Peter W.F. Wilson, & Robert M. Califf. (2006). Clinical trial issues in weight-loss therapy. American Heart Journal. 151(3). 633–642. 16 indexed citations
16.
Shen, Minxue, Sonja I. Berndt, Nathaniel Rothman, et al.. (2005). Polymorphisms in the DNA base excision repair genes APEX1 and XRCC1 and lung cancer risk in Xuan Wei, China.. PubMed. 25(1B). 537–42. 65 indexed citations
17.
Ginsburg, Geoffrey S., Mark Donahue, & L. Kristin Newby. (2005). Prospects for Personalized Cardiovascular Medicine. Journal of the American College of Cardiology. 46(9). 1615–1627. 45 indexed citations
18.
Lan, Qing, Minxue Shen, Sonja I. Berndt, et al.. (2005). Smoky coal exposure, NBS1 polymorphisms, p53 protein accumulation, and lung cancer risk in Xuan Wei, China. Lung Cancer. 49(3). 317–323. 38 indexed citations
19.
Donahue, Mark & Andrew S. Allen. (2005). Genetic association studies in cardiology. American Heart Journal. 149(6). 964–970. 7 indexed citations
20.
Kandzari, David E., J.Conor O’Shea, Benjamin H. Trichon, et al.. (2002). Highlights from the American Heart Association annual scientific sessions 2001: November 11 to 14, 2001. American Heart Journal. 143(2). 217–228. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emmanuel Androulakis Breakdown of academic impact, for papers by Fragiska Sigala Breakdown of academic impact, for papers by Andrzej Surdacki Breakdown of academic impact, for papers by Thimoteus Speer Breakdown of academic impact, for papers by Nima Ghasemzadeh Breakdown of academic impact, for papers by Demetrios Vlahakos Breakdown of academic impact, for papers by Marta Brambilla Breakdown of academic impact, for papers by Mirjam Schuchardt Breakdown of academic impact, for papers by Jürgen Meyer Breakdown of academic impact, for papers by Danny J. Eapen
Rankless by CCL
2026